Bristol-Myers Squibb Co (XSWX:BMY)
CHF 50.31 +0.70 (+1.42%) Market Cap: 102.29 Bil Enterprise Value: 131.58 Bil PE Ratio: 17.28 PB Ratio: 6.26 GF Score: 78/100

Bristol-Myers Squibb Co Virtual Investor Presentation on Hematology Programs Transcript

Dec 11, 2025 / 02:00PM GMT
Operator

Welcome to the Bristol-Myers Squibbs hematology drug development update conference call.

All participants will be in a listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the key followed by 0.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot